Literature DB >> 29303016

A Toxicological Evaluation of Chlamydomonas reinhardtii, a Green Algae.

Timothy S Murbach1, Róbert Glávits2, John R Endres1, Gábor Hirka2, Adél Vértesi2, Erzsébet Béres2, Ilona Pasics Szakonyiné2.   

Abstract

There is a current worldwide interest in developing novel sustainable nonanimal nutritional sources, and one such source is the green algae Chlamydomonas reinhardtii, the only green algae that has been studied as a model organism for many biological processes ranging from photosynthesis to flagellar movement. However, its potential as a safe nutritional source for use in various foods has not been thoroughly investigated. To assess the safety of C reinhardtii for use as a nutritional human food ingredient, in accordance with internationally accepted standards, the genotoxic potential and repeated-dose oral toxicity of the dried C reinhardtii (THN 6) algal biomass was investigated. The following studies were conducted: (1) a bacterial reverse mutation test, (2) an in vitro mammalian chromosomal aberration test, (3) an in vivo mammalian micronucleus test, and (4) a 28-day repeated-dose oral toxicity study in rats. No evidence of mutagenicity or genotoxic activity was observed in the first 3 tests under the applied test systems. In the 28-day study, male and female Hsd.Han Wistar rats were exposed to daily doses of 0, 1,000, 2,000, and 4,000 mg/kg bw by gavage. Following 28 days of continuous exposure, no mortality or treatment-related adverse effects were observed and no target organs were identified. Therefore, a no observed adverse effect level was concluded as 4,000 mg/kg bw/day, the highest dose tested.

Entities:  

Keywords:  Chlamydomonas reinhardtii; NOAEL; algal biomass; green algae; mutagenicity; safety; toxicity

Mesh:

Year:  2018        PMID: 29303016     DOI: 10.1177/1091581817746109

Source DB:  PubMed          Journal:  Int J Toxicol        ISSN: 1091-5818            Impact factor:   2.032


  12 in total

1.  Evaluation of acute oral toxicity, embryotoxicity and cytotoxicity of the polar fraction of Parkinsonia aculeata aerial parts extract.

Authors:  Tamires Meira Menezes; Wyndly Daniel Cardoso Gaião; Larissa Caroline de Almeida Sousa Lima; Ana Katarina Bezerra da Silva; Laísa Wanessa Santos Lima; Áurea Marcela de Souza Pereira; Luciano Clemente da Silva; Valdir Luna da Silva; Eryvelton de Souza Franco; Silvania Tavares Paz; Carina Scanoni Maia; Tânia Maria Sarmento da Silva; Maria Bernadete de Sousa Maia
Journal:  Toxicol Res (Camb)       Date:  2020-02-21       Impact factor: 3.524

2.  Fabrication of cell plastics composed only of unicellular green alga Chlamydomonas reinhardtii as a raw material.

Authors:  Akihito Nakanishi; Kohei Iritani; Akane Tsuruta; Naotaka Yamamoto; Marina Watanabe; Nanami Ozawa; Masahiko Watanabe; Kuan Zhang; Ayaka Tokudome
Journal:  Appl Microbiol Biotechnol       Date:  2022-06-09       Impact factor: 5.560

3.  The Entry Blocker Peptide Produced in Chlamydomonas reinhardtii Inhibits Influenza Viral Replication in vitro.

Authors:  Karen Lizbeth Reyes-Barrera; Ruth Elena Soria-Guerra; Rogelio López-Martínez; Leonor Huerta; Nohemí Salinas-Jazmín; Carlos Cabello-Gutiérrez; Ángel Gabriel Alpuche-Solís
Journal:  Front Plant Sci       Date:  2021-05-12       Impact factor: 5.753

Review 4.  Harnessing the Algal Chloroplast for Heterologous Protein Production.

Authors:  Edoardo Andrea Cutolo; Giulia Mandalà; Luca Dall'Osto; Roberto Bassi
Journal:  Microorganisms       Date:  2022-03-30

5.  CITRIC: cold-inducible translational readthrough in the chloroplast of Chlamydomonas reinhardtii using a novel temperature-sensitive transfer RNA.

Authors:  Rosanna Young; Saul Purton
Journal:  Microb Cell Fact       Date:  2018-11-24       Impact factor: 5.328

6.  A Toxicological Evaluation of Methylliberine (Dynamine®).

Authors:  Timothy S Murbach; Róbert Glávits; John R Endres; Amy E Clewell; Gábor Hirka; Adél Vértesi; Erzsébet Béres; Ilona Pasics Szakonyiné
Journal:  J Toxicol       Date:  2019-10-27

7.  Update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 15: suitability of taxonomic units notified to EFSA until September 2021.

Authors:  Kostas Koutsoumanis; Ana Allende; Avelino Alvarez-Ordóñez; Declan Bolton; Sara Bover-Cid; Marianne Chemaly; Robert Davies; Alessandra De Cesare; Friederike Hilbert; Roland Lindqvist; Maarten Nauta; Luisa Peixe; Giuseppe Ru; Marion Simmons; Panagiotis Skandamis; Elisabetta Suffredini; Pier Sandro Cocconcelli; Pablo Salvador Fernández Escámez; Miguel Prieto-Maradona; Amparo Querol; Lolke Sijtsma; Juan Evaristo Suarez; Ingvar Sundh; Just Vlak; Fulvio Barizzone; Michaela Hempen; Lieve Herman
Journal:  EFSA J       Date:  2022-01-27

8.  Improved high-throughput screening technique to rapidly isolate Chlamydomonas transformants expressing recombinant proteins.

Authors:  Ashley E Sproles; Anthony Berndt; Francis J Fields; Stephen P Mayfield
Journal:  Appl Microbiol Biotechnol       Date:  2022-02-07       Impact factor: 4.813

Review 9.  Perspectives for Glyco-Engineering of Recombinant Biopharmaceuticals from Microalgae.

Authors:  Lorenzo Barolo; Raffaela M Abbriano; Audrey S Commault; Jestin George; Tim Kahlke; Michele Fabris; Matthew P Padula; Angelo Lopez; Peter J Ralph; Mathieu Pernice
Journal:  Cells       Date:  2020-03-05       Impact factor: 6.600

10.  Downstream Processing of Chlamydomonas reinhardtii TN72 for Recombinant Protein Recovery.

Authors:  Laura Stoffels; Arran Finlan; Gareth Mannall; Saul Purton; Brenda Parker
Journal:  Front Bioeng Biotechnol       Date:  2019-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.